OUFClass II
Everolimus Immunoassay
21 CFR 862.3840 / Clinical Toxicology
OUF is the FDA product code for Everolimus Immunoassay, a class II device type, regulated under 21 CFR 862.3840. FDA's definition for this code reads: "To quantify everolimus in whole blood". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- OUF
- Device name
- Everolimus Immunoassay
- FDA definition
- To quantify everolimus in whole blood.
- Regulation
- 21 CFR 862.3840
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 2
- Ingested recalls
- 1
Clearances, product code OUF
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
Applicants with the most clearances
Product code OUF| Applicant | Clearances |
|---|---|
| Microgenics Corporation | 2 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
